Search Type: drug or dietary supplement name
Search Term: risedronate (ACTONEL, ATELVIA)

Drug Profiles | Disease and Drug Family Information | Worst Pills, Best Pills Newsletter Articles

Drug and Dietary Supplement Profiles

A comprehensive review of the safety and effectiveness of this drug. If the drug is not a Do Not Use product, information on adverse effects, drug interactions and how to use the medication are included.
Search results below include drug profiles where your selected drug is a secondary subject of discussion

Disease and Drug Family Information

Search results below include Disease and Drug Family Information where your selected drug is a secondary subject of discussion
  • Ulcers and Gastroesophageal Reflux Disease (GERD) [hide all summaries]
    There are nondrug treatments, with no safety concerns, and less expensive drugs that may be effective for GERD; these should be tried before you use any drugs for heartburn. First, try to avoid foods that trigger your condition (e.g., fatty foods, onions, caffeine, peppermint, and chocolate), and avoid alcohol, smoking, and tight clothing. Second, avoid food, and particularly alcohol, within two or three hours of bedtime. Third, elevate the head of the bed about six inches or sleep with extra pillows.

Worst Pills, Best Pills Newsletter Articles

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a secondary subject of discussion
  • Review of the Osteoporosis Drug Denosumab (PROLIA) [hide all summaries]
    (April 2019)
    Learn why we have designated Prolia as Do Not Use for treatment of osteoporosis in women and men.
  • DUAVEE, Hot Flashes and Bone Health [hide all summaries]
    (September 2015)
    Learn why the new combination of conjugated estrogens plus bazedoxifene (DUAVEE) is a bad choice for treating hot flashes and improving bone health in menopausal women.
  • New Warnings for Bone Drug Denosumab (PROLIA) [hide all summaries]
    (November 2014)
    Learn about new warnings recently issued by the FDA about the bone drug denosumab, a medicine previously designated as Do Not Use by Public Citizen’s Health Research Group.
  • Drug Mix-Ups [hide all summaries]
    (June 2011)
    This article lists 355 drugs with names that are often confused with similar-sounding drug names. Find out what you can do to prevent getting the wrong drug.
  • Avoiding Overuse of Proton Pump Inhibitors (PPIs) [hide all summaries]
    (March 2008)
    This article reviews evidence for the international epidemic of overuse of proton pump inhibitors (PPI), drugs used to treat ulcers and gastroesophageal reflux disease (GERD). There were 70 million prescriptions filled in U.S. pharmacies in 2006 for the four leading PPI drugs: esomeprazole (NEXIUM), lansoprazole (PREVACID), pantoprazole (PROTONIX) and rabeprazole (ACIPHIX). Find out about several serious side effects of these drugs such as increased community-acquired pneumonia, increased hip fractures and acute kidney inflammation. Learn about alternatives to using PPIs.
  • Don't Get Sold By Drug Ads on TV, Says Study [hide all summaries]
    (May 2007)
    Not only does this study find that consumer drug ads are not educational, it also says that the ads may oversell the benefits of the drugs and could put the public health in danger. For example, of the 24 drugs included in this advertising study, seven are listed as Do Not Use in Worst Pills, Best Pills publications. You should not rely on direct-to-consumer television advertisements as a source of drug information.
  • A Review of Ibandronate (BONIVA) For Osteoporosis [hide all summaries]
    (October 2006)
    Although this osteoporosis drug has been shown to decrease vertebral fractures, which involve the bones that make up the spine, the drug did not show any decrease in nonvertebral fractures, such as hip fractures, in postmenopausal women. We know more about the older, alternative drugs for osteoporosis.

SHOW primary search results for risedronate (ACTONEL, ATELVIA)

Copyright © 2019 Public Citizen's Health Research Group. All rights reserved.